Paper42465461
Discovery of non-nucleoside inhibitors of the enterovirus D68 3D polymerase through crystallographic fragment and high-throughput biochemical screening.
Biswas I and 13 others. bioRxiv, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Discovery of non-nucleoside inhibitors of the enterovirus D68 3D polymerase through crystallographic fragment and high-throughput biochemical screening. Papers, record 42465461. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42465461
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Discovery of non-nucleoside inhibitors of the enterovirus D68 3D polymerase through crystallographic fragment and high-throughput biochemical screening.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| U19 AI171110 | NIAID NIH HHS | United States | U19AI171110 | PubMed |
Source NIH RePORTER
References60
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24103767 | Ligand efficiency as a guide in fragment hit selection and optimization. | Drug Discov Today Technol | 2010 | https://conductscience.org/library/papers/24103767 | PubMed |
| 2 | 28081720 | Acute flaccid myelitis associated with enterovirus-D68 infection in an otherwise healthy child. | Virol J | 2017 | https://conductscience.org/library/papers/28081720 | PubMed |
| 3 | 28177307 | AceDRG: a stereochemical description generator for ligands. | Acta Crystallogr D Struct Biol | 2017 | https://conductscience.org/library/papers/28177307 | PubMed |
| 4 | 20124692 | XDS. | Acta Crystallogr D Biol Crystallogr | 2010 | https://conductscience.org/library/papers/20124692 | PubMed |
| 5 | 29910922 | A poised fragment library enables rapid synthetic expansion yielding the first reported inhibitors of PHIP(2), an atypical bromodomain. | Chem Sci | 2016 | https://conductscience.org/library/papers/29910922 | PubMed |
| 6 | 29482893 | Enterovirus D68 and acute flaccid myelitis-evaluating the evidence for causality. | Lancet Infect Dis | 2018 | https://conductscience.org/library/papers/29482893 | PubMed |
| 7 | 29533234 | DIALS: implementation and evaluation of a new integration package. | Acta Crystallogr D Struct Biol | 2018 | https://conductscience.org/library/papers/29533234 | PubMed |
| 8 | 10838414 | A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. | J Biomol Screen | 1999 | https://conductscience.org/library/papers/10838414 | PubMed |
| 9 | 26851276 | Thumb Site 2 Inhibitors of Hepatitis C Viral RNA-dependent RNA Polymerase Allosterically Block the Transition from Initiation to Elongation. | J Biol Chem | 2016 | https://conductscience.org/library/papers/26851276 | PubMed |
| 10 | 23408636 | Conformational flexibility of the Dengue virus RNA-dependent RNA polymerase revealed by a complex with an inhibitor. | J Virol | 2013 | https://conductscience.org/library/papers/23408636 | PubMed |
| 11 | 23183437 | Preclinical characterization of GS-9669, a thumb site II inhibitor of the hepatitis C virus NS5B polymerase. | Antimicrob Agents Chemother | 2013 | https://conductscience.org/library/papers/23183437 | PubMed |
| 12 | 31863580 | A nucleobase-binding pocket in a viral RNA-dependent RNA polymerase contributes to elongation complex stability. | Nucleic Acids Res | 2020 | https://conductscience.org/library/papers/31863580 | PubMed |
| 13 | 18184655 | Structural insights into mechanisms of catalysis and inhibition in Norwalk virus polymerase. | J Biol Chem | 2008 | https://conductscience.org/library/papers/18184655 | PubMed |
| 14 | 28659472 | Crystal Structure and Thermostability Characterization of Enterovirus D68 3Dpol. | J Virol | 2017 | https://conductscience.org/library/papers/28659472 | PubMed |
| 15 | 21460454 | REFMAC5 for the refinement of macromolecular crystal structures. | Acta Crystallogr D Biol Crystallogr | 2011 | https://conductscience.org/library/papers/21460454 | PubMed |
| 16 | 19073276 | Ligand efficiency and fragment-based drug discovery. | Drug Discov Today | 2009 | https://conductscience.org/library/papers/19073276 | PubMed |
| 17 | 16456546 | The structure of a protein primer-polymerase complex in the initiation of genome replication. | EMBO J | 2006 | https://conductscience.org/library/papers/16456546 | PubMed |
| 18 | 28436492 | A multi-crystal method for extracting obscured crystallographic states from conventionally uninterpretable electron density. | Nat Commun | 2017 | https://conductscience.org/library/papers/28436492 | PubMed |
| 19 | 31779114 | Concepts and Core Principles of Fragment-Based Drug Design. | Molecules | 2019 | https://conductscience.org/library/papers/31779114 | PubMed |
| 20 | 26984786 | Discovery of Potent Non-Nucleoside Inhibitors of Dengue Viral RNA-Dependent RNA Polymerase from a Fragment Hit Using Structure-Based Drug Design. | J Med Chem | 2016 | https://conductscience.org/library/papers/26984786 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42465461
GET https://conductscience.org/api/papers/v1/42465461/references?page=2